NNVC News 3.45 Nanoviricides Inc (NNVC)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nanoviricides Inc (NNVC) 3.45 $NNVC

NanoViricides Won the IAIR AWARD as Best North American Company for Leadership in the Nanomedicine Sector
Business Wire - Wed Apr 16, 7:43AM CDT
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company" has won the prestigious "IAIR Award" as the "Best North American Company for Leadership in the Nanomedicine Sector."

NanoViricides, Inc. President Dr. Anil R. Diwan Recognized as "Researcher of the Year" by BusinessNewHaven, a Connecticut Area Business Journal
Business Wire - Mon Mar 31, 7:55AM CDT
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company" announced today that Anil R. Diwan, Ph.D., President, Chairman, and co-Founder of the Company was recognized as the "2014 Researcher of the Year" by BusinessNewHaven, a business journal, and New Haven Magazine, publications that serve the state of Connecticut.

SeeThruEquity Initiates Research Coverage on NanoViricides, Inc.
Business Wire - Thu Mar 27, 8:01AM CDT
SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on NanoViricides, Inc. (NYSE-MKT:NNVC), a development stage company that is creating special purpose nanomaterials for viral therapy.

NanoViricides awarded fundamental PCT patents in Australia and the Philippines for antiviral applications and diseases
M2 - Tue Mar 25, 6:00AM CDT
Nanomaterials company NanoViricides (NYSE MKT:NNVC) reported on Monday the receipt of fundamental PCT patents in Australia and the Philippines based on its nanoviricides technology.

NanoViricides, Inc. Announces Issuance of Fundamental Patents in Australia and the Philippines
Business Wire - Mon Mar 24, 6:00AM CDT
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company" , announced today that a fundamental PCT patent application, on which the nanoviricides(R) technology is based, has resulted in additional issued patents in Australia and the Philippines.

NanoViricides, Inc. Has Posted Dr. Seymour's CEO Letter on the Company Website - Dr. Seymour to Present Today at the Roth Capital Conference
Business Wire - Wed Mar 12, 6:01AM CDT
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company" has posted the Company's CEO Dr. Seymour's "Letter to Shareholders" on its website (www.nanoviricides.com) yesterday. Dr. Seymour has provided a calendar year end overview of the Company for the benefit of the shareholders in this letter. In response to inquiries Dr. Seymour has received from several shareholders, this letter also discusses the strong performance of NanoViricides, Inc. since it was founded in 2005, the Company's continued progress in developing its platform technology, its rich and wide pipeline of industry-leading broad-spectrum antiviral drug candidates, the global intellectual property leadership, the Company's strong corporate governance, the Company's frugal business strategy that has helped the Company produce a strong and wide drug pipeline at a very low cost of development compared to the industry, and select highlights of what the Company expects to achieve in calendar year 2014 and the near future.

NanoViricides Inc. Denies Rumor That It Is Being Acquired For $4.5B
Business Wire - Fri Mar 07, 6:00AM CST
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company" denies the statement made in a blog post on the Seeking Alpha website that it is being acquired for between $2.25B and $4.5B.

NanoViricides, Inc. Announces It Has Commenced Action Against Seeking Alpha to Obtain Identity of the Anonymous Short Seller
Business Wire - Wed Mar 05, 6:01AM CST
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company" announces that it has filed a special proceeding in the Supreme Court of the State of New York to compel Seeking Alpha to disclose the identity of the person who wrote and published a defamatory, malicious, and libelous article about the Company on February 11, 2014, on the Seeking Alpha website. The writer identified self as a short seller in the article. The Company believes that the writer and/or others with whom the writer was in contact, had established and maintained a significant short position in the Company's common stock, and that these parties in collusion profited from the drop in the Company's share price that occurred subsequent to the posting of the article, at the expense of the Company's shareholders and the Company's position.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of NANOVIRICIDES, INC. for Possible Violations of Federal Securities Laws
Business Wire - Mon Mar 03, 11:45AM CST
Levi & Korsinsky is investigating NanoViricides, Inc. ("NanoViricides" or the "Company" (NYSE MKT:NNVC) for possible violations of federal securities laws.

Triphase Receives FDA Orphan Drug Designation for Marizomib in Multiple Myeloma
Business Wire - Thu Feb 27, 7:01AM CST
Triphase Accelerator Corporation today announced that marizomib, its novel, potent proteasome inhibitor, has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA)'s Office of Orphan Products Development for the treatment of multiple myeloma. The orphan drug designation will provide Triphase with 7-year marketing exclusivity for marizomib and other benefits upon FDA approval.

NanoViricides, Inc. Reports its President & Chairman Dr. Diwan Purchased its Common Stock in the Open Market
Business Wire - Wed Feb 26, 6:00AM CST
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company" , reports that its President & Chairman Dr. Anil Diwan has purchased its common stock in the open market after the Company filed its quarterly report. Dr. Diwan has repaid $83,900 to the Company as a result of the "short term profits" accrued from this transaction.

INVESTOR ALERT: Investigation of NanoViricides, Inc. Announced by Glancy Binkow & Goldberg LLP
Business Wire - Tue Feb 25, 5:32PM CST
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of NanoViricides, Inc. ("NanoViricides" or the "Company" (NYSE MKT:NNVC) concerning possible violations of federal securities laws. NanoViricides is a nano-biopharmaceutical company engaged in the discovery, development and commercialization of therapeutics for the treatment of viral infections. The investigation is focused on the Company's business, operations and financial performance.

NanoViricides Reports that it is Evaluating Purchase of the New Facility and cGMP Pilot Production Plant instead of a Lease
Business Wire - Thu Feb 20, 6:00AM CST
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company" reported today that construction of the modern R&D Lab and cGMP Clinical Production facility in Shelton, CT, is nearing completion with some weather-related delays. The Company reports that the R&D lab section of the facility is ahead of schedule. Once construction of the cGMP Clean Room Production Suite is completed, the project will enter the facility testing and validation phase. The Company is performing certain scale-up studies and production of the quantities of FluCide(TM) needed for the "Tox Package" study at its current facility, as previously reported. The Company anticipates transitioning staff to the new facility upon obtaining a Certificate of Occupancy.

NanoViricides, Inc. Files Quarterly Report - Reports a Strong Cash Position Sufficient for Clinical Trials of its First Two Drug Candidates
Business Wire - Tue Feb 18, 6:00AM CST
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company" , has filed its quarterly report with the Securities and Exchange Commission on Friday, February 14th, in a timely fashion. The submission can be downloaded from the SEC website at http://www.sec.gov/Archives/edgar/data/137900...79_10q.htm.

5 of Last Week's Biggest Losers
Rick Munarriz, The Motley Fool - Motley Fool - Sun Feb 16, 9:30AM CST
There's never a shortage of losers in the stock market. Let's take a closer look at five of this past week's biggest sinkers. Company Feb. 14 Weekly Loss Infoblox   $19.41 42% ...

NanoViricides, Inc. Demands Retraction of the Baseless and Inaccurate Libelous Article by an Anonymous Short Seller Posted on SeekingAlpha Website
Business Wire - Fri Feb 14, 9:06AM CST
NanoViricides, Inc. (NYSE MKT:NNVC) (the "Company" has demanded from Seeking Alpha the removal of a damaging, baseless and inaccurate article posted by a person who was shorting NNVC common stock.

Harwood Feffer LLP Announces Investigation of NanoViricides, Inc.
PR Newswire - Wed Feb 12, 7:30PM CST
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against NanoViricides, Inc. ("NNVC" or the "Company" (NYSE: NNVC) and its board of directors concerning whether the board has breached its fiduciary duties to shareholders or violated the federal securities laws.

Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of NanoViricides, Inc.
Business Wire - Wed Feb 12, 4:32PM CST
Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of NanoViricides, Inc. ("NanoViricides" or the "Company" (NYSE MKT:NNVC) concerning possible violations of federal securities laws. The investigation is focused on the Company's business, operations and financial performance.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Search Is Squeezing Clicks, Not Killing Content Yet

Updated Category News Views 77

A search result that answers the question before earning a click is a nasty little disruption, and marketers are plainly feeling around for solid ground. Goodfirms surveyed 192 content marketing professionals for its 2026 Content Engagement Metrics report, and the headline is more resilient than the prevailing panic: 66.3% said organic website traffic grew over the prior...

Continue Reading
Subaru's 650-Car Anniversary Bet Is Delightfully Small

Updated Category News Views 119

Gold brake calipers may sound like a fussy correction, yet that little detail tells you exactly who Subaru is trying to please. The company has revised its announcement for the 2027 WRX tS GD25 and BRZ tS ZC15, clarifying the anniversary-model names and changing the WRX description from red-painted to gold-painted Brembo calipers. Nobody should confuse a corrected paint...

Continue Reading
Somerville’s New Immersive Bet Has Room to Grow Locally

Updated Category News Views 172

A passcard, a hidden door, and 12,000 square feet of mischief have landed at Somernova. Edge of Elsewhere, the new flagship attraction from Boston-area creative studio Midnight Mansion, is open in Somerville’s Union Square as of November 18, 2026. It is part interactive art installation, part puzzle game, part physical story world. That sounds delightfully odd, which is...

Continue Reading
JOYY’s Ad Engine Gives Q3 Growth Some Real Teeth Now

Updated Category News Views 107

Three engines are finally pulling the cart at JOYY, and that is a far more interesting sight than another quarter of livestreaming merely holding together. The company reported third-quarter 2026 revenue of US$624.6 million, up 15.6% from a year earlier and 5.7% sequentially. Those are sturdy numbers, especially for a business that investors have long tended to box in as...

Continue Reading
J. Harmon Tests a Smarter Cannabis Accessory Niche

Updated Category News Views 53

Aisle Space Is the Real Prize Most cannabis accessory launches arrive dressed up like a gimmick and disappear before anyone has reordered them. J. Harmon has a more sensible target: give women products that look deliberate, work in everyday routines and do not demand designer-level money. The brand is set to debut at MJBizCon 2026 in Las Vegas, with LUVBUDS handling...

Continue Reading
Thanksgiving AI Talk Needs Better Safety Questions

Updated Category News Views 102

Thanksgiving has somehow acquired a new household hazard: somebody casually pasting private information into a chatbot between football and dessert. SBS CyberSecurity’s point is sensible, and it lands because this is no longer a niche tech habit. Pew Research Center says 49% of U.S. adults use AI chatbots, up from roughly one-third in 2024. That kind of adoption curve...

Continue Reading
Chainlink, UBS Take $2 Trillion Notes Toward Onchain

Updated Category News Views 9

Paperwork is a lousy moat when a bank can automate the mess. Chainlink and UBS are putting that proposition to work in structured notes, a market with more than $2 trillion in outstanding notional and, frankly, an awful lot of operational clutter. Their production solution uses the Chainlink Runtime Environment, or CRE, to connect UBS systems, smart contracts, market data...

Continue Reading
Resolve Adds Cahaba in Birmingham Pain-Care Expansion

Updated Category News Views 226

Pain-care consolidation has a peculiar way of looking tidy in a release and messy in the real world. Resolve Pain Solutions announced on November 18, 2026, that it has acquired Cahaba Pain and Spine Care, an established provider serving greater Birmingham, Alabama. On its face, this is a straightforward expansion move: buy a respected local practice, retain its physician...

Continue Reading
Arbor Realty's Loan Mess Meets a Dividend Shutdown

Updated Category News Views 89

A dividend suspension lands differently when the loan book is already coughing up smoke. Arbor Realty Trust’s latest disclosed numbers are not the sort that investors can shrug off as one ugly quarter and forget by Friday. The company reported a third-quarter 2026 GAAP net loss of $85.4 million, suspended its quarterly cash dividend effective immediately, and described...

Continue Reading
Colon Cleanse Advice Deserves a Careful Read First

Updated Category News Views 23

Wellness copy can sound harmless right up until it blurs comfort guidance with health guidance. HelloNation’s feature on what to expect after a colon cleanse, drawing on Suzanne Childre of Gentle Wellness Center in Santa Monica, lays out a fairly familiar recovery script: drink water, rest, eat lightly, expect some bowel changes, and do not panic over a little fatigue....

Continue Reading

Top 5 Most Recently Viewed Articles

RTX and Cebu Pacific Forge Strategic Engine Maintenance Alliance

Updated Category News Views 201

Strategic Partnership Between RTX and Cebu Pacific In an exciting development for aviation partnerships, Pratt & Whitney, an RTX (NYSE: RTX) business, and Cebu Pacific have entered into a comprehensive long-term agreement aimed at maintaining the efficiency and reliability of Cebu Pacific’s GTF engine fleet. This strategic collaboration underlines the critical role of...

Continue Reading
Hellenic Music Ensemble Embarks on North American Tour

Updated Category News Views 172

The Hellenic Music Ensemble's Exciting North American Tour The Hellenic Music Ensemble is set to take North American audiences on a mesmerizing journey through Greece's rich musical heritage in 2026. Led by the talented Natassa Bofiliou and Giannis Haroulis, alongside special guest star Judy Kuhn, this tour promises to be a landmark event. Celebrating Greek Composers This...

Continue Reading
University of Maryland's Groundbreaking Fundraising Initiative

Updated Category News Views 258

University of Maryland Launches Its Largest Fundraising Campaign The University of Maryland proudly announces its most ambitious fundraising endeavor to date, aimed at elevating education and research. Titled Forward: The University of Maryland Campaign for the Fearless, this initiative seeks to raise an impressive $2.5 billion. With the goal of advancing the university's...

Continue Reading
New Insights on Dowlais Group Plc's Recent Activity

Updated Category News Views 203

Understanding Recent Trading Disclosures by Dowlais Group Plc As the financial landscape continuously evolves, public disclosures play a crucial role in ensuring transparency, trust, and regulatory compliance. Dowlais Group Plc, a notable player in the market, recently had transaction disclosures that are vital for investors and stakeholders alike. The company's exemplary...

Continue Reading
Stock Market Updates: Gains, Losses, and Oil Inventory Trends

Updated Category News Views 142

Recent U.S. Stock Market Movements As the trading day nears its end, U.S. stock indices show promising trends, with the S&P 500 making notable gains recently. This uptrend reflects a resilient market which continues to respond positively amidst economic fluctuations. Key Market Index Performances On Thursday, the Dow Jones Industrial Average climbed by 0.24%, reaching...

Continue Reading